Skip to main content

Paul Brodbeck to Present at Continuous Manufacturing Forum

September 17-19 | Princeton, NJ

Join us at the Continuous Manufacturing Forum, where Continua’s Paul Brodbeck will be speaking on Advances in Technology.

The Continuous Manufacturing Forum serves as a catalyst for compelling conversations, bringing together key opinion leaders in biotech and pharma. It unites executive leadership, directors, senior scientists, consultants, and a closely-knit network of CDMOs, academic leaders, and equipment providers.

Paul Brodbeck
Chief Technologist
Continua

VIEW AGENDA & REGISTER
MORE INSIGHTS & STORIES

The Next Step in Your Digital Strategy

Learn how to assess and build your DX strategy with a Digital Transformation Maturity Assessment.

The Ideal Architecture for Digital Transformation

Know the ‘current state’ and ‘future state’ of your business in real time with contextualized data from an enterprise-wide data hub.

The Business Case for Digital Transformation

Digital Transformation can unlock significant value across the entire supply chain and throughout the factory network.

Augmenting an MES

Bringing large amounts of data into your business systems requires the flexibility, security, and growth potential of a Unified Namespace ecosystem.

Integrating Lab Automation Systems

Learn how we integrated Nova FLEX cell culture analysis data with this pharma company’s plant control system to automate required actions.

Monitoring High-Value R&D Materials

This biotech company now monitors and tracks its R&D materials throughout the earliest stages of drug development using a UNS platform.

MES Data Informs Analytics

Explore several ways to extract MES data to support analytics: from hiring an MES engineer to querying the MES recipe, to creating a Unified Namespace.

Ideal Unified Namespace Pilots

Examples: Continuous Process Verification with batch-to-batch comparisons at different locations and Machine Learning with data from multiple systems.

MES Maintains Chain of Identity

This Cell/Gene Therapy customer’s autologous process required maintaining a strict chain of identity across the supply chain with no room for error.

MES Enables Predictability

By implementing an electronic batch record in MES, this customer practically eliminated errors—ultimately reducing finished goods inventory.